{"title":"Ceapin-A7 counteracts the protective effects of Lanreotide in endothelial cells","authors":"Md Matiur Rahman Sarker, Saikat Fakir, Madan Sigdel, Nektarios Barabutis","doi":"10.1016/j.amolm.2026.100104","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Pulmonary endothelial barrier dysfunction is characterized by increased vascular permeability, lung edema, and impaired gas exchange. Synthetic somatostatin analogs (SSA), including Lanreotide (LAN), have demonstrated cytoprotective effects in experimental models of endothelial injury, but the corresponding mechanisms mediating those effects are still unclear.</div></div><div><h3>Objective</h3><div>This study aimed to determine whether the unfolded protein response (UPR) sensor ATF6 is involved in the protective outcomes of LAN in lung endothelial cells.</div></div><div><h3>Methods</h3><div>Human and bovine pulmonary endothelial cells were exposed to Ceapin-A7, an ATF6 inhibitor, prior to LAN exposure. Protein expression levels of BiP, Grp94, MLC2, Cofilin, STAT1, STAT3, and stress kinases were assessed. Reactive oxygen species (ROS) generation was also measured, as well as paracellular permeability using FITC-Dextran assay.</div></div><div><h3>Results</h3><div>LAN enhanced protein expression of BiP and Grp94, decreased ROS production, suppressed STAT1, STAT3 and ERK1/2 phosphorylation, and improved barrier function. Those effects were counteracted by Ceapin-A7.</div></div><div><h3>Conclusions</h3><div>Our findings suggest that ATF6 inhibition opposes the beneficial effects of LAN in endothelial cells.</div></div>","PeriodicalId":72320,"journal":{"name":"Aspects of molecular medicine","volume":"7 ","pages":"Article 100104"},"PeriodicalIF":0.0000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aspects of molecular medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949688826000055","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/3 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Pulmonary endothelial barrier dysfunction is characterized by increased vascular permeability, lung edema, and impaired gas exchange. Synthetic somatostatin analogs (SSA), including Lanreotide (LAN), have demonstrated cytoprotective effects in experimental models of endothelial injury, but the corresponding mechanisms mediating those effects are still unclear.
Objective
This study aimed to determine whether the unfolded protein response (UPR) sensor ATF6 is involved in the protective outcomes of LAN in lung endothelial cells.
Methods
Human and bovine pulmonary endothelial cells were exposed to Ceapin-A7, an ATF6 inhibitor, prior to LAN exposure. Protein expression levels of BiP, Grp94, MLC2, Cofilin, STAT1, STAT3, and stress kinases were assessed. Reactive oxygen species (ROS) generation was also measured, as well as paracellular permeability using FITC-Dextran assay.
Results
LAN enhanced protein expression of BiP and Grp94, decreased ROS production, suppressed STAT1, STAT3 and ERK1/2 phosphorylation, and improved barrier function. Those effects were counteracted by Ceapin-A7.
Conclusions
Our findings suggest that ATF6 inhibition opposes the beneficial effects of LAN in endothelial cells.